Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2011

01-09-2011 | Epidemiology

Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study

Authors: Adriana Villaseñor, Anita Ambs, Rachel Ballard-Barbash, Kathy B. Baumgartner, Anne McTiernan, Cornelia M. Ulrich, Marian L. Neuhouser

Published in: Breast Cancer Research and Treatment | Issue 2/2011

Login to get access

Abstract

Inflammation is a suspected risk factor for breast cancer and its subsequent prognosis. The extent to which dietary and lifestyle factors might influence inflammation is important to examine. Specifically, dietary fiber may reduce systemic inflammation, but this relationship has not been examined among breast cancer survivors. We examined associations between dietary fiber and serum concentrations of C-reactive protein (CRP) and serum amyloid A (SAA), among 698 female breast cancer survivors from the Health, Eating, Activity, and Lifestyle (HEAL) Study. Data are from interviews and clinical visits conducted 24-months post-study enrollment. Multivariate-adjusted linear regression estimated associations of total, soluble, and insoluble fiber with serum concentrations of CRP and SAA. Logistic regression estimated the odds of elevated CRP (defined as >3.0 mg/l) across tertiles of dietary fiber intake. Mean total dietary fiber intake was 13.9 ± 6.4 g/day. Mean CRP and SAA were 3.32 ± 3.66 and 7.73 ± 10.23 mg/l, respectively. We observed a multivariate-adjusted inverse association between total dietary fiber intake and CRP concentrations (β, −0.029; 95% CI, −0.049, −0.008). Results for insoluble fiber were similar (β, −0.039; 95% CI, −0.064, −0.013). Among survivors who consumed >15.5 g/day of insoluble dietary fiber, a 49% reduction in the likelihood of having elevated CRP concentrations (OR, 0.51; 95% CI, 0.27, 0.95) was observed compared to those who consumed <5.4 g/day (P = 0.053). Our results suggest that diets high in fiber may benefit breast cancer survivors via reductions in systemic inflammation; elevated inflammation may be prognostic for reduced survival.
Literature
1.
go back to reference Rutter MK et al (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110(4):380–385PubMedCrossRef Rutter MK et al (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110(4):380–385PubMedCrossRef
2.
go back to reference Sattar N et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108(4):414–419 See commentPubMedCrossRef Sattar N et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108(4):414–419 See commentPubMedCrossRef
3.
go back to reference Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545 See commentPubMedCrossRef Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545 See commentPubMedCrossRef
4.
5.
go back to reference Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266PubMedCrossRef Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266PubMedCrossRef
6.
go back to reference Egeblad M, Littlepage LE, Werb Z (2005) The fibroblastic coconspirator in cancer progression. Cold Spring Harbor Symp Quant Biol 70:383–388PubMedCrossRef Egeblad M, Littlepage LE, Werb Z (2005) The fibroblastic coconspirator in cancer progression. Cold Spring Harbor Symp Quant Biol 70:383–388PubMedCrossRef
7.
go back to reference Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161–174PubMedCrossRef Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161–174PubMedCrossRef
10.
go back to reference Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759PubMedCrossRef Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759PubMedCrossRef
11.
go back to reference Pearson TA et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511 See commentPubMedCrossRef Pearson TA et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511 See commentPubMedCrossRef
12.
go back to reference Hara M et al (2007) Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 27(4C):3001–3004PubMed Hara M et al (2007) Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 27(4C):3001–3004PubMed
13.
go back to reference Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61(9):824–833PubMedCrossRef Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61(9):824–833PubMedCrossRef
14.
go back to reference Bolayirli M et al (2007) C-reactive protein as an acute phase protein in cancer patients. Med Oncol 24(3):338–344PubMedCrossRef Bolayirli M et al (2007) C-reactive protein as an acute phase protein in cancer patients. Med Oncol 24(3):338–344PubMedCrossRef
15.
go back to reference McSorley MA et al (2007) C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol 109(4):933–941PubMedCrossRef McSorley MA et al (2007) C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol 109(4):933–941PubMedCrossRef
16.
go back to reference Trichopoulos D et al (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2):381–384PubMedCrossRef Trichopoulos D et al (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2):381–384PubMedCrossRef
17.
go back to reference Plutzky J (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88(8A):10K–15KPubMedCrossRef Plutzky J (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88(8A):10K–15KPubMedCrossRef
18.
go back to reference Cottam DR et al (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14(5):589–600PubMedCrossRef Cottam DR et al (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14(5):589–600PubMedCrossRef
19.
go back to reference King DE et al (2005) Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 28(6):1487–1489PubMedCrossRef King DE et al (2005) Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 28(6):1487–1489PubMedCrossRef
20.
go back to reference Koenig W et al (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99(2):237–242PubMed Koenig W et al (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99(2):237–242PubMed
21.
go back to reference North CJ, Venter CS, Jerling JC (2009) The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 63(8):921–933PubMedCrossRef North CJ, Venter CS, Jerling JC (2009) The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 63(8):921–933PubMedCrossRef
22.
go back to reference Pereira MA, Pins JJ (2000) Dietary fiber and cardiovascular disease: experimental and epidemiologic advances. Curr Atheroscler Rep 2(6):494–502PubMedCrossRef Pereira MA, Pins JJ (2000) Dietary fiber and cardiovascular disease: experimental and epidemiologic advances. Curr Atheroscler Rep 2(6):494–502PubMedCrossRef
23.
go back to reference Kanauchi O et al (2003) Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 9(4):333–346PubMedCrossRef Kanauchi O et al (2003) Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 9(4):333–346PubMedCrossRef
24.
go back to reference Rosamond WD (2002) Dietary fiber and prevention of cardiovascular disease. J Am Coll Cardiol 39(1):57–59 See commentPubMedCrossRef Rosamond WD (2002) Dietary fiber and prevention of cardiovascular disease. J Am Coll Cardiol 39(1):57–59 See commentPubMedCrossRef
25.
go back to reference Slavin JL (2000) Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr 19(3 Suppl):300S–307SPubMed Slavin JL (2000) Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr 19(3 Suppl):300S–307SPubMed
26.
go back to reference Yin L, Laevsky G, Giardina C (2001) Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276(48):44641–44646PubMedCrossRef Yin L, Laevsky G, Giardina C (2001) Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276(48):44641–44646PubMedCrossRef
27.
go back to reference Ma Y et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women’s Health Initiative Observational Study. Nutrition 24(10):941–949PubMedCrossRef Ma Y et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women’s Health Initiative Observational Study. Nutrition 24(10):941–949PubMedCrossRef
28.
go back to reference King DE et al (2007) Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 167:502–506PubMedCrossRef King DE et al (2007) Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 167:502–506PubMedCrossRef
29.
go back to reference King DE, Egan BM, Geesey ME (2003) Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92(11):1335–1339 Erratum appears in Am J Cardiol. 2004 Mar 15;93(6):812PubMedCrossRef King DE, Egan BM, Geesey ME (2003) Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92(11):1335–1339 Erratum appears in Am J Cardiol. 2004 Mar 15;93(6):812PubMedCrossRef
30.
go back to reference Ma Y et al (2006) Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83(4):760–766PubMed Ma Y et al (2006) Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83(4):760–766PubMed
31.
go back to reference Ajani UA, Ford ES, Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr 134(5):1181–1185PubMed Ajani UA, Ford ES, Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr 134(5):1181–1185PubMed
32.
go back to reference Pierce BL et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437–3444PubMedCrossRef Pierce BL et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27(21):3437–3444PubMedCrossRef
33.
go back to reference American Cancer Society (2008) Cancer Facts & Figures 2008. Atlanta, American Cancer Society American Cancer Society (2008) Cancer Facts & Figures 2008. Atlanta, American Cancer Society
34.
go back to reference Romieu I et al (2004) Carbohydrates and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 13(8):1283–1289PubMed Romieu I et al (2004) Carbohydrates and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 13(8):1283–1289PubMed
35.
go back to reference Irwin ML et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97(7):1746–1757PubMedCrossRef Irwin ML et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97(7):1746–1757PubMedCrossRef
36.
go back to reference Irwin ML et al (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36(9):1484–1491PubMed Irwin ML et al (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36(9):1484–1491PubMed
37.
go back to reference McTiernan A et al (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21(10):1961–1966PubMedCrossRef McTiernan A et al (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21(10):1961–1966PubMedCrossRef
38.
go back to reference Patterson RE et al (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9(3):178–187PubMedCrossRef Patterson RE et al (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9(3):178–187PubMedCrossRef
39.
go back to reference Ledue TB et al (1998) Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 44(4):878–879PubMed Ledue TB et al (1998) Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 44(4):878–879PubMed
40.
go back to reference Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45(12):2136–2141PubMed Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45(12):2136–2141PubMed
41.
go back to reference Wener MH, Daum PR, McQuillan GM (2000) The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27(10):2351–2359PubMed Wener MH, Daum PR, McQuillan GM (2000) The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27(10):2351–2359PubMed
42.
go back to reference Ford ES (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22(12):1971–1977 See commentPubMedCrossRef Ford ES (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22(12):1971–1977 See commentPubMedCrossRef
43.
go back to reference Visser M et al (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131–2135 See commentPubMedCrossRef Visser M et al (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131–2135 See commentPubMedCrossRef
44.
go back to reference Tracy RP et al (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17(10):2167–2176PubMedCrossRef Tracy RP et al (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17(10):2167–2176PubMedCrossRef
45.
46.
go back to reference King DE et al (2003) Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 35(4):575–581PubMedCrossRef King DE et al (2003) Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 35(4):575–581PubMedCrossRef
47.
go back to reference Pierce BL et al (2008) Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 114(1):155–167PubMedCrossRef Pierce BL et al (2008) Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 114(1):155–167PubMedCrossRef
48.
go back to reference Kinlay S, Selwyn AP (2003) Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol 91(4A):9B–13BPubMedCrossRef Kinlay S, Selwyn AP (2003) Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol 91(4A):9B–13BPubMedCrossRef
49.
go back to reference Bays HE et al (2002) Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. Am J Cardiol 90(9):942–946PubMedCrossRef Bays HE et al (2002) Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. Am J Cardiol 90(9):942–946PubMedCrossRef
50.
go back to reference Haffner SM et al (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106(6):679–684 See commentPubMedCrossRef Haffner SM et al (2002) Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106(6):679–684 See commentPubMedCrossRef
51.
go back to reference Al Murri AM et al (2007) Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer 96(6):891–895PubMedCrossRef Al Murri AM et al (2007) Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer 96(6):891–895PubMedCrossRef
52.
go back to reference Cohen J et al (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum, Hillsdale, p 425 Cohen J et al (2003) Applied multiple regression/correlation analysis for the behavioral sciences, 3rd edn. Erlbaum, Hillsdale, p 425
53.
go back to reference Galisteo M, Duarte J, Zarzuelo A (2008) Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 19(2):71–84PubMedCrossRef Galisteo M, Duarte J, Zarzuelo A (2008) Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 19(2):71–84PubMedCrossRef
54.
go back to reference Basu A, Devaraj S, Jialal I (2006) Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 26(5):995–1001PubMedCrossRef Basu A, Devaraj S, Jialal I (2006) Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 26(5):995–1001PubMedCrossRef
55.
go back to reference Sell H et al (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 95(6):2892–2896PubMedCrossRef Sell H et al (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 95(6):2892–2896PubMedCrossRef
56.
go back to reference Delzenne NM, Cani PD (2005) A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8(6):636–640PubMedCrossRef Delzenne NM, Cani PD (2005) A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8(6):636–640PubMedCrossRef
57.
go back to reference Cani PD et al (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90(5):1236–1243PubMedCrossRef Cani PD et al (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90(5):1236–1243PubMedCrossRef
58.
go back to reference Vijay-Kumar M et al (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328(5975):228–231PubMedCrossRef Vijay-Kumar M et al (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328(5975):228–231PubMedCrossRef
59.
go back to reference Aggarwal S et al (2010) Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation. Clin Exp Allergy 40(1):85–93PubMed Aggarwal S et al (2010) Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation. Clin Exp Allergy 40(1):85–93PubMed
60.
go back to reference Jacobs DR Jr, Andersen LF, Blomhoff R (2007) Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr 85(6):1606–1614PubMed Jacobs DR Jr, Andersen LF, Blomhoff R (2007) Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr 85(6):1606–1614PubMed
61.
go back to reference Qi L et al (2006) Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29(2):207–211PubMedCrossRef Qi L et al (2006) Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29(2):207–211PubMedCrossRef
62.
go back to reference Neuhouser ML et al (2008) Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women’s Health Initiative. Am J Epidemiol 167(10):1247–1259PubMedCrossRef Neuhouser ML et al (2008) Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women’s Health Initiative. Am J Epidemiol 167(10):1247–1259PubMedCrossRef
Metadata
Title
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study
Authors
Adriana Villaseñor
Anita Ambs
Rachel Ballard-Barbash
Kathy B. Baumgartner
Anne McTiernan
Cornelia M. Ulrich
Marian L. Neuhouser
Publication date
01-09-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1474-6

Other articles of this Issue 2/2011

Breast Cancer Research and Treatment 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine